The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease
2004 ◽
Vol 1019
(1-2)
◽
pp. 246-254
◽
2016 ◽
Vol 283
◽
pp. 308-317
◽
Keyword(s):
2018 ◽
Vol WCP2018
(0)
◽
pp. OR24-3
2014 ◽
Vol 18
(11)
◽
pp. 1293-1304
◽
2010 ◽
Vol 30
(1)
◽
pp. 316-324
◽
2007 ◽
Vol 147
(2)
◽
pp. 354-372
◽
Keyword(s):
Keyword(s):
2005 ◽
Vol 102
(50)
◽
pp. 18189-18194
◽
Keyword(s):